Inside informationEnglish
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Valneva SE
- Filed
- 07/08/2025, 07:17
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 111770_20250807